DEA Archived Press Releases

Press Releases before January 20, 2025
622 Results - Showing 371 to 380
PRESS RELEASE

DEA Kicks Off Red Ribbon Campaign

WASHINGTON - The United States Drug Enforcement (DEA) this week kicks off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in March 1985. Officially, Red Ribbon Week...
PRESS RELEASE

DEA Reduces Amount Of Opioid Controlled Substances To Be Manufactured In 2017

WASHINGTON - The United States Drug Enforcement (DEA) has reduced the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the United States in 2017 by 25 percent or more, according to a being published in the Federal Register tomorrow and available for public...
PRESS RELEASE

Call For Entries: National Red Ribbon Weekar Photo Contest Starts This Week IPadar And $1,000 To Be Awarded To Top Family & School Entries

WASHINGTON - In an effort to prevent drug use while educating youth, the National Family (NFP), invites families and schools across America to participate in its 6th Annual National Red Ribbon Week Photo Contest. The contest, which is co-sponsored by the Drug Enforcement (DEA), will be held in conjunction with...
PRESS RELEASE

U.S. And Chinese Drug Enforcement Agencies Meet On Synthetic Opioid Efforts

WASHINGTON - This week the heads of the national drug-control agencies for the United States and the People’s Republic of China, Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and Director (DG) Hu Minglang from the Narcotics Control (NCB) of the Ministry of Public Security, met at DEA Headquarters in Arlington...
PRESS RELEASE

DEA Issues Carfentanil Warning To Police And Public

WASHINGTON - DEA has issued a public warning to the public and law enforcement nationwide about the health and safety risks of carfentanil. Carfentanil is a synthetic opioid that is 10,000 times more potent than morphine and 100 times more potent than fentanyl, which itself is 50 times more potent...
PRESS RELEASE

Busted Behind Bars: Drug Case Leads Feds To Prison Dealer

PHOENIX - The DEA announced the recent conviction of Luis Alfonso Felix-Hernandez, an already incarcerated subject who was found guilty of multiple federal charges after it was discovered he was continuing his drug trafficking operations from within prison walls. Information provided to federal agents by Mesa Police Department detectives indicated...
PRESS RELEASE

DEA Announces Intent To Schedule Kratom

WASHINGTON - The Drug Enforcement (DEA) today announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety. Mitragynine and 7-hydroxymitragynine are found in kratom, which is a tropical tree indigenous...
PRESS RELEASE

DEA Announces Actions Related To Marijuana And Industrial Hemp

WASHINGTON - The Drug Enforcement (DEA) announced several marijuana- related actions, including actions regarding scientific research and scheduling of marijuana, as well as principles on the cultivation of industrial hemp under the Agricultural Act of 2014. DEA Publishes Responses to Two Pending Petitions to Reschedule Marijuana - DEA has denied...
PRESS RELEASE

DEA Targets Tucson Synthetic Drug Traffickers

PHOENIX - DEA led multiple enforcement operations in Tucson and the surrounding area this morning as part of a long-term federal investigation involving the sales and distribution of synthetic cannabinoids, aka “spice.” DEA coordinated the service of 32 federal search warrants in Tucson, Arizona; Denver, Colorado and Long Beach, California...
PRESS RELEASE

DEA Investigation Leads To 42-Count Indictment And Arrest Of Arizona Doctor

PHOENIX - DEA Special Agent in Charge Doug Coleman and Attorney General Mark Brnovich announced the indictment of Dr. Harinder Kumar Takyar following a 42-count indictment by a state grand jury alleging Dr. Takyar prescribed controlled substances with no medical necessity and provided compensation for the referral of patients to...